Skip to main content

Advertisement

Log in

Comparison of preoperative continuation and discontinuation of aspirin in patients undergoing total hip or knee arthroplasty

  • Original Article • KNEE - ARTHROPLASTY
  • Published:
European Journal of Orthopaedic Surgery & Traumatology Aims and scope Submit manuscript

Abstract

Introduction

Preoperative discontinuation of aspirin (acetylsalicylic acid) can reduce bleeding risk but may increase the risk of perioperative cardiovascular events.

Materials and methods

We retrospectively assessed the impact of preoperative continuation versus discontinuation of aspirin compared with a control group in a cohort of 739 consecutive patients undergoing total hip (THA) (n = 396) or knee arthroplasty (TKA) (n = 343) at a tertiary hospital. Bleeding risk, local complications, orthopaedic outcome, and cardiac and cerebral complications were assessed.

Results

Four hundred and sixty-five patients did not receive antithrombotic or full-dose anticoagulant medication, 175 patients were taking low-dose aspirin, 99 vitamin K antagonists, clopidogrel, or a combination of these drugs. Of the patients taking aspirin, 139 discontinued and 36 continued aspirin. Blood loss and local bleeding complications were comparable in these two groups. TKA patients who continued aspirin more frequently showed marked knee swelling after 1 week than those discontinuing aspirin (35.1 vs. 81.3 %; p = 0.001). However, orthopaedic outcome did not differ significantly between the two groups. There was a trend towards an increased risk of cardiac complications in patients who discontinued aspirin (6.5 vs. 0.0 %; p = 0.107).

Conclusions

Continuation or discontinuation of aspirin did not show a statistically significant difference in the risk of relevant perioperative bleeding complications in our study. Continuation of aspirin was associated with a transitory increase in knee swelling, but had no effect on orthopaedic outcome. Continuation of aspirin may be associated with a favourable perioperative cardiac outcome. Our data support perioperative continuation of aspirin intake in patients undergoing THA or TKA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mont MA, Jacobs JJ (2011) AAOS clinical practice guideline: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg 19:777–778

    Article  PubMed  Google Scholar 

  2. Despotis GJ, Filos KS, Zoys TN et al (1996) Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 82:13–21

    CAS  PubMed  Google Scholar 

  3. Ferraris VA, Ferraris SP, Joseph O et al (2002) Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 235:820–827

    Article  PubMed  PubMed Central  Google Scholar 

  4. Vuylsteke A, Oduro A, Cardan E, Latimer RD (1997) Effect of aspirin in coronary artery bypass grafting. YJCAN 11:831–834

    CAS  Google Scholar 

  5. Hofstad B, Nesbakken A, Eritsland J et al (2008) Should platelet inhibitors be discontinued before gastrointestinal endoscopy? Tidsskr Nor Laegeforen 128:2440–2442

    PubMed  Google Scholar 

  6. Ferraris VA, Swanson E (1983) Aspirin usage and perioperative blood loss in patients undergoing unexpected operations. Surg Gynecol Obstet 156:439–442

    CAS  PubMed  Google Scholar 

  7. Ardekian L, Gaspar R, Peled M et al (2000) Does low-dose aspirin therapy complicate oral surgical procedures? J Am Dent Assoc 131:331–335

    Article  CAS  PubMed  Google Scholar 

  8. Assia EI, Raskin T, Kaiserman I et al (1998) Effect of aspirin intake on bleeding during cataract surgery. J Cataract Refract Surg 24:1243–1246

    Article  CAS  PubMed  Google Scholar 

  9. Decoene C, Vincentelli A, Fabre O et al (2005) Late thrombosis of a drug-eluting coronary stent after antiplatelet therapy discontinuation. Ann Fr Anesth Reanim 24:1275–1277. doi:10.1016/j.annfar.2005.07.075

    Article  CAS  PubMed  Google Scholar 

  10. Möllmann H, Nef HM, Hamm CW, Elsässer A (2009) How to manage patients with need for antiplatelet therapy in the setting of (un-)planned surgery. Clin Res Cardiol 98:8–15. doi:10.1007/s00392-008-0718-x

    Article  CAS  PubMed  Google Scholar 

  11. Murphy JT, Fahy BG (2007) Balancing perioperative risks in orthopedic surgery: the patient with a coronary stent. Orthopedics 30:931–6– quiz 937–8

  12. Devereaux PJ, Mrkobrada M, Sessler DI et al (2014) Aspirin in patients undergoing noncardiac surgery. N Engl J Med 370:1494–1503

    Article  CAS  PubMed  Google Scholar 

  13. Manning BJ, O’Brien N, Aravindan S et al (2004) The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury 35:121–124

    Article  PubMed  Google Scholar 

  14. Anekstein Y, Tamir E, Halperin N, Mirovsky Y (2004) Aspirin therapy and bleeding during proximal femoral fracture surgery. Clin Orthop 418:205–208

    Article  Google Scholar 

  15. Thaler HW, Frisee F, Korninger C (2010) Platelet aggregation inhibitors, platelet function testing, and blood loss in hip fracture surgery. J Trauma 69:1217–20– discussion 1221. doi:10.1097/TA.0b013e3181f4ab6a

  16. Kristensen SD, Knuuti J, Saraste A et al (2014) ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 35:2383–2431

    Article  PubMed  Google Scholar 

  17. Amsterdam EA, Wenger NK, Brindis RG et al (2014) AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130:2354–2394

    Article  PubMed  Google Scholar 

  18. Bellamy N, Buchanan WW, Goldsmith CH et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Miodrag Filipovic, Department of Anaesthesia, Kantonsspital St. Gallen, Switzerland, for his input and providing his expertise that greatly assisted this work.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Rahel Meier or Regula Marthy.

Ethics declarations

Conflict of interest

Author MK reports grants and personal fees from Zimmer Pty, Ltd, personal fees from Springer Editor, outside the submitted work. All other authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Patient data were analysed retrospectively and anonymized according to the requirements of the local ethics committee (canton of St. Gallen) that waved the study.

Additional information

Rahel Meier and Regula Marthy have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meier, R., Marthy, R., Saely, C.H. et al. Comparison of preoperative continuation and discontinuation of aspirin in patients undergoing total hip or knee arthroplasty. Eur J Orthop Surg Traumatol 26, 921–928 (2016). https://doi.org/10.1007/s00590-016-1830-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00590-016-1830-7

Keywords

Navigation